A Phase 3 interventional study of Bupivacaine in Cesarean Delivery, sponsored by Cristália Produtos Químicos Farmacêuticos Ltda.. Withdrawn at 2 sites in Brazil. Open to female participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-03-26.
Sponsored by Cristália Produtos Químicos Farmacêuticos Ltda. · Phase 3, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The purpose of this study is to determine if the mixture of enantiomers of bupivacaine (bupivacaine S75:R25) dos not represent inferiority efficacy and safety compare to the racemic mixture of enantiomers of bupivacaine (bupivacaine S50:R50).
The enantiomeric mixture of bupivacaine S75:R25 (75% levobupivacaine and 25% bupivacaine) was develop to be a safety regional anesthetic in substitution to racemic bupivacaine (S50:R50).
Cristália Produtos Químicos Farmacêuticos Ltda. is the lead sponsor of 14 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
3 ml subarachnoid block
Drug: Bupivacaine
3 ml for subarachnoid block
Drug: Bupivacaine
single dose of 15 mg by a slow injection rate of 1 mL/s
Also known as: Marcaine
latency of sensitive block at T6
The anesthesiologist will evaluate the loss of pain to pin-prick in T10.
Time frame: loss of pain in T6
duration of the anesthesia
Time to recover the sensibility due to the anesthetic
Time frame: recovery of the sensibility
Degree of motor block
Evaluated by the Bromage scale after the injection of the anesthetic solution
Time frame: End of motor block
maximal level of the sensitive blockade
Evaluation by pin-prick every 2 minutes after the injection of the anesthetic solution.
Time frame: last level of sensitive blockade
Maternal cardiocirculatory and respiratory parameters
systolic and diastolic blood pressure (SBP and DBP), heart rate (HR), and oxygen saturation (SpO2) are evaluate during the study
Time frame: During the study
Parturients ambulation
Will be measured the time that the parturients ambulate, due to de regression of the motor blockade
Time frame: regression of the motor blockade
Visceral pain
Visceral pain will be assessed at the time of suture of the peritoneum.
Time frame: suture of the peritoneum
Neonatal repercussions
Evaluation of the Apgar index in the first and fifth minutes.
Time frame: birth of the neonatal
This study is withdrawn, as verified in Jan 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Bupivacaine
Cristália Produtos Químicos Farmacêuticos Ltda.